|
1
|
Fan L, Zheng Y, Yu KD, Liu GY, Wu J, Lu
JS, Shen KW, Shen ZZ and Shao ZM: Breast cancer in a transitional
society over 18 years: Trends and present status in Shanghai,
China. Breast Cancer Res Treat. 117:409–416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hemminki K, Mousavi SM, Sundquist J and
Brandt A: Does the breast cancer age at diagnosis differ by
ethnicity? A study on immigrants to Sweden. Oncologist. 16:146–154.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng S, Bai JQ, Li J, Fan JH, Pang Y,
Song QK, Huang R, Yang HJ, Xu F, Lu N and Qiao YL: The pathologic
characteristics of breast cancer in China and its shift during
1999–2008: A national-wide multicenter cross-sectional image over
10 years. Int J Cancer. 131:2622–2631. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song QK, Wang XL, Zhou XN, Yang HB, Li YC,
Wu JP, Ren J and Lyerly HK: Breast cancer challenges and screening
in China: Lessons from current registry data and population
screening studies. Oncologist. 20:773–779. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Si W, Li Y, Han Y, Zhang F, Wang Y, Li Y,
Linghu RX, Zhang X and Yang J: Epidemiological and
clinicopathological trends of breast cancer in Chinese patients
during 1993 to 2013: A retrospective study. Medicine (Baltimore).
94:e8202015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lynch HT, Snyder C and Lynch J: Hereditary
breast cancer: Practical pursuit for clinical translation. Ann Surg
Oncol. 19:1723–1731. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shuen AY and Foulkes WD: Inherited
mutations in breast cancer genes-risk and response. J Mammary Gland
Biol Neoplasia. 16:3–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kurian AW, Gong GD, John EM, Miron A,
Felberg A, Phipps AI, West DW and Whittemore AS: Performance of
prediction models for BRCA mutation carriage in three racial/ethnic
groups: Findings from the Northern California Breast Cancer Family
Registry. Cancer Epidemiol Biomarkers Prev. 18:1084–1091. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kurian AW, Gong GD, Chun NM, Mills MA,
Staton AD, Kingham KE, Crawford BB, Lee R, Chan S, Donlon SS, et
al: Performance of BRCA1/2 mutation prediction models in Asian
Americans. J Clin Oncol. 26:4752–4758. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vogel KJ, Atchley DP, Erlichman J, Broglio
KR, Ready KJ, Valero V, Amos CI, Hortobagyi GN, Lu KH and Arun B:
BRCA1 and BRCA2 genetic testing in Hispanic patients: Mutation
prevalence and evaluation of the BRCAPRO risk assessment model. J
Clin Oncol. 25:4635–4641. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim YC, Zhao L, Zhang H, Huang Y, Cui J,
Xiao F, Downs B and Wang SM: Prevalence and spectrum of BRCA
germline variants in mainland Chinese familial breast and ovarian
cancer patients. Oncotarget. 7:9600–9612. 2016.PubMed/NCBI
|
|
15
|
den Dunnen JT and Antonarakis SE: Mutation
nomenclature extensions and suggestions to describe complex
mutations: A discussion. Hum Mutat. 15:7–12. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American college
of medical genetics and genomics and the association for molecular
pathology. Genet Med. 17:405–424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kang E, Seong MW, Park SK, Lee JW, Lee J,
Kim LS, Lee JE, Kim SY, Jeong J, Han SA, et al: The prevalence and
spectrum of BRCA1 and BRCA2 mutations in Korean population: Recent
update of the Korean hereditary breast cancer (KOHBRA) study.
Breast Cancer Res Treat. 151:157–168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Seong MW, Cho SI, Kim KH, Chung IY, Kang
E, Lee JW, Park SK, Lee MH, Choi DH, Yom CK, et al: A
multi-institutional study of the prevalence of BRCA1 and BRCA2
large genomic rearrangements in familial breast cancer patients.
BMC Cancer. 14:6452014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weitzel JN, Clague J, Martir-Negron A,
Ogaz R, Herzog J, Ricker C, Jungbluth C, Cina C, Duncan P, Unzeitig
G, et al: Prevalence and type of BRCA mutations in Hispanics
undergoing genetic cancer risk assessment in the southwestern
United States: A report from the Clinical Cancer Genetics Community
Research Network. J Clin Oncol. 31:210–216. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Blay P, Santamaria I, Pitiot AS, Luque M,
Alvarado MG, Lastra A, Fernández Y, Paredes A, Freije JM and Balbin
M: Mutational analysis of BRCA1 and BRCA2 in hereditary breast and
ovarian cancer families from Asturias (Northern Spain). BMC Cancer.
13:2432013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Konstantopoulou I, Tsitlaidou M, Fostira
F, Pertesi M, Stavropoulou AV, Triantafyllidou O, Tsotra E,
Tsiftsoglou AP, Tsionou C, Droufakou S, et al: High prevalence of
BRCA1 founder mutations in Greek breast/ovarian families. Clin
Genet. 85:36–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Riahi A, Kharrat M, Ghourabi ME, Khomsi F,
Gamoudi A, Lariani I, May AE, Rahal K and Chaabouni-Bouhamed H:
Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in
patients with familial and early-onset breast/ovarian cancer from
Tunisia. Clin Genet. 87:155–160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang J, Pei R, Pang Z, Ouyang T, Li J,
Wang T, Fan Z, Fan T, Lin B and Xie Y: Prevalence and
characterization of BRCA1 and BRCA2 germline mutations in Chinese
women with familial breast cancer. Breast Cancer Res Treat.
132:421–428. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Sun J, Chen J, Yao L, Ouyang T,
Li J, Wang T, Fan Z, Fan T, Lin B and Xie Y: Comprehensive analysis
of BRCA1 and BRCA2 germline mutations in a large cohort of 5931
Chinese women with breast cancer. Breast Cancer Res Treat.
158:455–462. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang X, Wu J, Lu J, Liu G, Di G, Chen C,
Hou Y, Sun M, Yang W, Xu X, et al: Identification of a
comprehensive spectrum of genetic factors for hereditary breast
cancer in a Chinese population by next-generation sequencing. PLoS
One. 10:e01255712015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peto J, Collins N, Barfoot R, Seal S,
Warren W, Rahman N, Easton DF, Evans C, Deacon J and Stratton MR:
Prevalence of BRCA1 and BRCA2 gene mutations in patients with
early-onset breast cancer. J Natl Cancer Inst. 91:943–949. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Anonymity: Guidelines and specifications
for the diagnosis and treatment of breast cancer in Chinese Cancer
Society (Version 2015). China Oncology. 25:692–754. 2015.
|
|
28
|
Hall MJ, Reid JE, Burbidge LA, Pruss D,
Deffenbaugh AM, Frye C, Wenstrup RJ, Ward BE, Scholl TA and Noll
WW: BRCA1 and BRCA2 mutations in women of different ethnicities
undergoing testing for hereditary breast-ovarian cancer. Cancer.
115:2222–2233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li WF, Hu Z, Liu XY, Zhang B, Cao MZ, Wang
YS, Zhao L, Liu YB, Yuan WT, Shen ZZ, et al: BRCA1 germ line
mutations in Chinese early-onset breast cancer patients. Zhonghua
Yi Xue Yi Chuan Xue Za Zhi. 24:499–504. 2007.(In Chinese).
PubMed/NCBI
|
|
30
|
Choi DH, Lee MH, Bale AE, Carter D and
Haffty BG: Incidence of BRCA1 and BRCA2 mutations in young Korean
breast cancer patients. J Clin Oncol. 22:1638–1645. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Suter NM, Ray RM, Hu YW, Lin MG, Porter P,
Gao DL, Zaucha RE, Iwasaki LM, Sabacan LP, Langlois MC, et al:
BRCA1 and BRCA2 mutations in women from Shanghai China. Cancer
Epidemiol Biomarkers Prev. 13:181–189. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li N, Zhang X, Cai Y, Xu X, Zhang L, Pan
KF, Wu LY and Wang MR: BRCA1 germline mutations in Chinese patients
with hereditary breast and ovarian cancer. Int J Gynecol Cancer. 16
Supp 1:S172–S178. 2006. View Article : Google Scholar
|
|
33
|
Hu Z, Li WF, Liu XY, Zhang B, Cao MZ, Wang
YS, Zhao L, Song CG, Lu JS, Wu J, et al: 5589del8: The recurrent
mutation of BRCA1 gene in Chinese breast cancer patients. Zhonghua
Yi Xue Yi Chuan Xue Za Zhi. 24:378–381. 2007.(In Chinese).
PubMed/NCBI
|
|
34
|
Anonymity: ClinVar, . NCBI. https://www.ncbi.nlm.nih.gov/clinvar/variation/55591/#summary-evidence12–Jan.
2016
|
|
35
|
Kwong A, Wong LP, Wong HN, Law FB, Ng EK,
Tang YH, Chan WK, Ho LS, Kwan KH, Poon M, et al: A BRCA2 founder
mutation and seven novel deleterious BRCA mutations in southern
Chinese women with breast and ovarian cancer. Breast Cancer Res
Treat. 117:683–686. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kwong A, Ng EK, Wong CL, Law FB, Au T,
Wong HN, Kurian AW, West DW, Ford JM and Ma ES: Identification of
BRCA1/2 founder mutations in Southern Chinese breast cancer
patients using gene sequencing and high resolution DNA melting
analysis. PLoS One. 7:e439942012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Adem C, Soderberg CL, Hafner K, Reynolds
C, Slezak JM, Sinclair CS, Sellers TA, Schaid DJ, Couch F, Hartmann
LC and Jenkins RB: ERBB2, TBX2, RPS6KB1, and MYC alterations in
breast tissues of BRCA1 and BRCA2 mutation carriers. Genes
Chromosomes Cancer. 41:1–11. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Eerola H, Heikkilä P, Tamminen A,
Aittomäki K, Blomqvist C and Nevanlinna H: Histopathological
features of breast tumours in BRCA1, BRCA2 and mutation-negative
breast cancer families. Breast Cancer Res. 7:R93–R100. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shao J, Yang J, Wang JN, Qiao L, Fan W,
Gao QL and Feng YJ: Effect of BRCA2 mutation on familial breast
cancer survival: A systematic review and meta-analysis. J Huazhong
Univ Sci Technolog Med Sci. 35:629–634. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhong Q, Peng HL, Zhao X, Zhang L and
Hwang WT: Effects of BRCA1- and BRCA2-related mutations on ovarian
and breast cancer survival: A meta-analysis. Clin Cancer Res.
21:211–220. 2015. View Article : Google Scholar : PubMed/NCBI
|
